1. Home
  2. KZIA vs WATT Comparison

KZIA vs WATT Comparison

Compare KZIA & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • WATT
  • Stock Information
  • Founded
  • KZIA 1994
  • WATT 2012
  • Country
  • KZIA Australia
  • WATT United States
  • Employees
  • KZIA N/A
  • WATT N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • WATT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • KZIA Health Care
  • WATT Technology
  • Exchange
  • KZIA Nasdaq
  • WATT Nasdaq
  • Market Cap
  • KZIA 9.0M
  • WATT 9.3M
  • IPO Year
  • KZIA 1999
  • WATT 2014
  • Fundamental
  • Price
  • KZIA $8.04
  • WATT $7.64
  • Analyst Decision
  • KZIA Strong Buy
  • WATT
  • Analyst Count
  • KZIA 2
  • WATT 0
  • Target Price
  • KZIA $14.00
  • WATT N/A
  • AVG Volume (30 Days)
  • KZIA 17.4K
  • WATT 53.3K
  • Earning Date
  • KZIA 06-05-2025
  • WATT 07-29-2025
  • Dividend Yield
  • KZIA N/A
  • WATT N/A
  • EPS Growth
  • KZIA N/A
  • WATT N/A
  • EPS
  • KZIA N/A
  • WATT N/A
  • Revenue
  • KZIA $1,549,158.00
  • WATT $1,976,000.00
  • Revenue This Year
  • KZIA N/A
  • WATT $1,028.91
  • Revenue Next Year
  • KZIA $49.25
  • WATT $117.65
  • P/E Ratio
  • KZIA N/A
  • WATT N/A
  • Revenue Growth
  • KZIA 248983.08
  • WATT 434.05
  • 52 Week Low
  • KZIA $2.86
  • WATT $3.67
  • 52 Week High
  • KZIA $39.05
  • WATT $81.00
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 50.26
  • WATT 40.00
  • Support Level
  • KZIA $7.52
  • WATT $7.11
  • Resistance Level
  • KZIA $8.33
  • WATT $7.82
  • Average True Range (ATR)
  • KZIA 0.62
  • WATT 0.57
  • MACD
  • KZIA 0.04
  • WATT 0.04
  • Stochastic Oscillator
  • KZIA 67.93
  • WATT 41.96

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.

Share on Social Networks: